Accéder au contenu
Merck
  • Targeting deficiencies in mitochondrial respiratory complex I and functional uncoupling exerts anti-seizure effects in a genetic model of temporal lobe epilepsy and in a model of acute temporal lobe seizures.

Targeting deficiencies in mitochondrial respiratory complex I and functional uncoupling exerts anti-seizure effects in a genetic model of temporal lobe epilepsy and in a model of acute temporal lobe seizures.

Experimental neurology (2013-11-26)
Kristina A Simeone, Stephanie A Matthews, Kaeli K Samson, Timothy A Simeone
RÉSUMÉ

Mitochondria actively participate in neurotransmission by providing energy (ATP) and maintaining normative concentrations of reactive oxygen species (ROS) in both presynaptic and postsynaptic elements. In human and animal epilepsies, ATP-producing respiratory rates driven by mitochondrial respiratory complex (MRC) I are reduced, antioxidant systems are attenuated and oxidative damage is increased. We report that MRCI-driven respiration and functional uncoupling (an inducible antioxidant mechanism) are reduced and levels of H2O2 are elevated in mitochondria isolated from KO mice. Experimental impairment of MRCI in WT hippocampal slices via rotenone reduces paired-pulse ratios (PPRs) at mossy fiber-CA3 synapses (resembling KO PPRs), and exacerbates seizure-like events in vitro. Daily treatment with AATP [a combination therapy composed of ascorbic acid (AA), alpha-tocopherol (T), sodium pyruvate (P) designed to synergistically target mitochondrial impairments] improved mitochondrial functions, mossy fiber PPRs, and reduced seizure burden index (SBI) scores and seizure incidence in KO mice. AATP pretreatment reduced severity of KA-induced seizures resulting in 100% protection from the severe tonic-clonic seizures in WT mice. These data suggest that restoration of bioenergetic homeostasis in the brain may represent a viable anti-seizure target for temporal lobe epilepsy.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Peroxyde d'hydrogène solution, contains inhibitor, 30 wt. % in H2O, ACS reagent
Sigma-Aldrich
Peroxyde d'hydrogène solution, 30 % (w/w) in H2O, contains stabilizer
Sigma-Aldrich
Peroxyde d'hydrogène solution, 50 wt. % in H2O, stabilized
Sigma-Aldrich
L-acide ascorbique, powder, suitable for cell culture, γ-irradiated
Sigma-Aldrich
L-acide ascorbique, BioXtra, ≥99.0%, crystalline
Sigma-Aldrich
Lascorbate de (+)-sodium, crystalline, ≥98%
Sigma-Aldrich
L-acide ascorbique, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Pyruvic acid, 98%
Sigma-Aldrich
Lascorbate de (+)-sodium, BioXtra, ≥99.0% (NT)
Sigma-Aldrich
Lascorbate de (+)-sodium, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
L-acide ascorbique, reagent grade, crystalline
Sigma-Aldrich
L-acide ascorbique, 99%
Sigma-Aldrich
Peroxyde d'hydrogène solution, contains inhibitor, 35 wt. % in H2O
Supelco
L-acide ascorbique, analytical standard
Sigma-Aldrich
L-acide ascorbique, reagent grade
Supelco
L-acide ascorbique, Pharmaceutical Secondary Standard; Certified Reference Material
Millipore
Peroxyde d'hydrogène solution, 3%, suitable for microbiology
Sigma-Aldrich
L-acide ascorbique, ACS reagent, ≥99%
Sigma-Aldrich
L-acide ascorbique, meets USP testing specifications
Supelco
Peroxyde d'hydrogène solution, ≥30%, for trace analysis
Sigma-Aldrich
(+)-α-Tocopherol, from vegetable oil, Type V, ~1000 IU/g
Sigma-Aldrich
Peroxyde d'hydrogène solution, contains inhibitor, 30 wt. % in H2O, meets USP testing specifications
Sigma-Aldrich
Peroxyde d'hydrogène solution, 34.5-36.5%
Sigma-Aldrich
L-acide ascorbique, FCC, FG
Supelco
Lascorbate de (+)-sodium, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Pyruvic acid, ≥97%, FG
Sigma-Aldrich
L-acide ascorbique, BioUltra, ≥99.5% (RT)
Sigma-Aldrich
(+)-α-Tocopherol, Type VI, from vegetable oil, liquid (≥0.88M based on potency, density and molecular wt.), BioReagent, suitable for insect cell culture, ≥1000 IU/g
Sigma-Aldrich
Pyruvic acid, 95%
Supelco
Peroxyde d'hydrogène solution, 30 % (w/w), for ultratrace analysis